CRISPR QC Analytics Platform gives the information and understanding they require to fuel the safest, most effective gene editing results.
CRISPR QC has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
CRISPR QC's investors include Serra Ventures, Xcellerant Ventures, BioTools Innovator, CaerusX Ventures.
CRISPR QC is headquartered in San Diego, United States.
CRISPR QC Analytics Platform gives the information and understanding they require to fuel the safest, most effective gene editing results.
CRISPR QC is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CRISPR QC — Funding & Investors." VCBacked, January 4, 2024, https://www.vcbacked.co/company/crispr-qc. Accessed October 30, 2026.
VCBacked. (2024). CRISPR QC — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/crispr-qc
{{cite web |title=CRISPR QC — Funding & Investors |url=https://www.vcbacked.co/company/crispr-qc |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated